More people getting

faster access to care

Partners

The QUID-NASH research program works in strong synergy with all its partners

Private partners

Academic partners

Servier is the second French pharmaceutical laboratory with 5,000 employees in France, its headquarters, two production sites (98% of active ingredients are produced in France), two research institutes (more than 70% of researchers are based in France ) and an investigation center. With this solid local footprint, the Group plays an important role as an economic and social player through its research and production activities.

 

Click here >
BioPredictive is dedicated to improve the management of liver diseases and offers diagnostic and prognostic blood tests for liver diseases.
Over 3 million tests performed worldwide. BioPredictive’s diagnosis and prognosis patented tests (FibroTest-ActiTest, SteatoTest, and just released NASH-FibroTest) are available at www.biopredictive.com
FibroTest App (free) including ElastoFibroTest and DAAFibroTest is also available on iPhone and Android.
We invite you to take a look at our online scientific library: http://library.biopredictive.com/
Click here >
Inserm is the only public research organization in France entirely dedicated to human health. Its objective is to promote the health of all by advancing knowledge about life and disease, treatment innovation, and public health research.

 

Click here >
AP-HP is the first european clinical trial promoter and the largest university hospital centre in Europe with its 6 affiliated universities divided into 12 hospital groups. AP-HP provides healthcare to 9 million patients per year, education and training for MDs and paramedics, and, research activities. AP-HP employs 100 000 professionals which makes it the first employer of its region, Ile-de-France.

 

Click here >
The French Alternative Energies and Atomic Energy Commission (CEA) is a key player in research, development and innovation in four main areas:

  • defence and security,
  • low carbon energies (nuclear and renewable energies),
  • technological research for industry,
  • fundamental research in the physical sciences and life sciences.

Drawing on its widely acknowledged expertise, the CEA actively participates in collaborative projects with a large number of academic and industrial partners.

 

 

 

Click here >
The laboratory Physics for Medicine Paris (Inserm, ESPCI Paris, CNRS) has been created in January 2019, in the continuity of the work of the research unit Inserm U979 Wave Physics for Medicine (former research unit within Institut Langevin Ondes et Images, Paris, France). Physics for Medicine Paris is directed by Prof. Mickael Tanter, and gathers 60 scientists (10 tenured researchers in physics and biology, 10 research engineers and technicians, 2 administrative staffs, and about ten postdoctoral fellows and thirty PhD students). The team develops innovative technologies for biomedical imaging and therapy, mostly based on ultrasound waves and new concepts of wave physics. Researchers of Physics for Medicine Paris are internationally renowned for having pioneered many innovations in the field of biomedical ultrasound, and for their ability to successfully translate fundamental research in new clinical devices.
Click here >
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sed tellus lobortis, tempor sem nec, placerat urna. Etiam arcu sapien, mollis vitae tortor vitae, tempus pellentesque sem. Ut congue, quam id finibus laoreet, elit massa posuere elit, nec aliquet magna libero vel lacus. Etiam rutrum mauris vitae aliquam volutpat. Vestibulum gravida lobortis auctor. Duis id vestibulum nisl, molestie iaculis odio. Vivamus lobortis a est eget malesuada. Nullam venenatis tincidunt efficitur. In id laoreet nulla. Nunc pulvinar sapien ipsum, quis pretium tellus consequat non. Proin laoreet vitae lacus vitae fringilla.

 

Click here >
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sed tellus lobortis, tempor sem nec, placerat urna. Etiam arcu sapien, mollis vitae tortor vitae, tempus pellentesque sem. Ut congue, quam id finibus laoreet, elit massa posuere elit, nec aliquet magna libero vel lacus. Etiam rutrum mauris vitae aliquam volutpat. Vestibulum gravida lobortis auctor. Duis id vestibulum nisl, molestie iaculis odio. Vivamus lobortis a est eget malesuada. Nullam venenatis tincidunt efficitur. In id laoreet nulla. Nunc pulvinar sapien ipsum, quis pretium tellus consequat non. Proin laoreet vitae lacus vitae fringilla.

 

Click here >

The clinical research unit in health economics is a transverse structure of the Delegation of Clinical Research and Innovation (DRCI) of the AP-HP which is responsible for piloting the research projects developed by the AP -HP and to follow all the research activities taking place within the institution:

nearly 3,000 research projects in progress, all promoters combined;

nearly 917 research projects for which the AP-HP promotes and manages;

more than 24,604 patients included in clinical trials promoting AP-HP.

 

Click here >